Neil Feldstein, MD
Doctor Neil A. Feldstein attended medical school at New York University, and then went on to complete his residency training at the Baylor School of Medicine, followed by his fellowship training at the New York University School of Medicine. Dr. Feldstein has been the director of the Division of Pediatric Neurological Surgery at the New York – Presbyterian Hospital since 1994. Under his directorship the division has grown to three full time pediatric neurological surgeons who cover all aspects of pediatric neurological surgery. Among his interests and expertise is a national reputation in the management of Chiari Malformations and SpinaDysraphism. He has an active practice in such subspecialty areas as brain and spinal cord tumors, craniofacial abnormalities, and vascular malformations such as Moyamoya, AVMs and cavernous malformations. In an effort to decrease operative time and morbidity as well as hospital stay Dr. Feldstein has begun to utilize endoscopic assistance to perform common procedures through smaller incisions. This is currently seen in the management of craniosynostosis, chiari malformations and in certain forms of hydrocephalus.
Jonathan Finlay, MD
Director of Neuro-Oncology
Nationwide Children's Hospital
Jonathan L. Finlay, MB, ChB, FRCP is the Program Director of Neuro-Oncology at Nationwide Children’s Hospital. Dr. Finlay is a tenured Professor of Pediatrics at The Ohio State University College of Medicine. He is an internationally recognized expert in pediatric brain tumors and has authored or co-authored over 200 peer-reviewed publications in leading medical journals and over 80 review articles and book chapters. Prior to coming to Nationwide Children’s, Dr. Finlay was the Director of the Neural Tumors Program at Children’s Hospital Los Angeles and served as Professor of Pediatrics, Neurology & Neurological Surgery at the Keck School of Medicine, University of Southern California. Between 1982 and 2003, he held faculty positions in Pediatric Oncology at Stanford University (1980-1982), University of Wisconsin-Madison (1982-1987), University of Pennsylvania (1987-1989), Cornell University/Memorial Sloan-Kettering Cancer Center (1989-1993) and New York University (1997-2003).
James Garvin, MD
Dr. James H. Garvin completed medical school at Thomas Jefferson University Medical College; he then went on to do both his internship and residency at the Children’s Hospital of Philadelphia, followed by his fellowship at the Dana-Farber Cancer Institute in Massachusetts. Dr. Garvin has numerous areas of expertise, including: Neuro-Oncology, Chemotherapy, Anemia, Iron Deficiency, Leukemia, Bone Marrow Transplant, and Pediatric Brain Tumors.
Stewart Goldman, MD
Children's Memorial Hospital, Chicago
Dr. Goldman completed his undergraduate education at the University of Iowa (BS, Psychology); he then attended medical school at Loyola University Stritch School of Medicine. After completing medical school he completed his internship and residency at Wyler Children’s Hospital, followed up by his fellowship at the University of Chicago Hospitals. As the current Medical Director of Neuro-Oncology and Director of the Clinical Trials Center at Ann& Robert H. Lurie Children’s Hospital of Chicago, Dr. Goldman also serves as an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. He is also the Gus Foundation Chair of Neuro-oncology.He encourages his patients to live their lives as normally as possible and is passionate about providing the best care and support he can for the patients and families he interacts with each and every day. Not only is Dr. Goldman a special member of the Children's l community, he is also an essential part of the Make-A-Wish Foundation of Illinois.
Theodore Moore, MD
Dr. Theodore B. Moore is the Clinical Director of Pediatric Hematology/Oncology and Director of the Pediatric Blood and Marrow Transplant Program at UCLA.He trained in Pediatric Hematology/Oncology at UCLA from 1992-1995, serving as a Clinical Instructor. He then took the position of Director of Pediatric Stem Cell Transplant at the Oregon Health and Science University in Portland, Oregon building the Pediatric Hematopoietic Stem Cell Transplant program, from its infancy.He returned to UCLA joining the UCLA School of Medicine faculty in 2001 with his current appointment in the Division of Pediatric Hematology/Oncology in the Department of Pediatrics. He is active in Clinical Research serving as the UCLA Principal Investigator for the Children's Oncology Group, the Pediatric Blood and Marrow Transplant Consortium, and the Pediatric Cancer Research Foundation Consortium. In addition he serves as the UCLA Site Director for the Glaser Pediatric Research Network.His areas of research interest are in Pediatric Hematopoietic Stem Cell Transplant, relapsed leukemia, and infections in the immunocompromised patient.
Mark Souweidane, MD
Weill Cornell Medical College
Dr. Mark M. Souweidane complete his undergraduate studies at the University of Michigan, he then went on to attend Wayne State University Medical School. His general surgery internship was completed at University of Michigan Hospitals and he subsequently did his neurosurgery residency at New York University, followed by his clinical fellowship for pediatric neurosurgery at the Hospital for Sick Children in Toronto. Dr. Souweidane has dedicated his career to the surgical treatment of children with brain and spinal disorders. He has gained international acclaim in minimally invasive endoscopic neurosurgery for the treatment of hydrocephalus, intraventricular brain tumors, colloid cysts, and congenital cysts. His other areas of expertise include brain and spinal cord tumors of childhood, Chiari malformations, congenital spinal disorders, arachnoid cysts, and pediatric vascular disorders. He is the principal investigator of a laboratory that is partly funded by the Pediatric Brain Tumor Foundation. Dr. Souweidane’s laboratory focuses on improving the outcome of children with brain tumors by studying experimental local delivery and brain tumor modeling.
Eileen Stark, MSN CPNP
New York Presbyterian/MSCHONY
Suzanne Wolden, MD
Since completing her medical training at the University of California, San Francisco and Stanford University in 1998, Dr. Suzanne Wolden has served as the primary pediatric radiation oncologist at the Memorial Sloan-Kettering Cancer Center in New York, NY. Children with tumors of the brain and spine make up a large portion her clinical practice. Dr. Wolden’s research has focused on ways to manipulate radiotherapy to maximize the therapeutic ratio between tumor control and toxicity. Specifically, her studies have defined new targeting strategies for brain tumors such as medulloblastoma and intracranial germ cell tumors. She is especially dedicated to improving treatment for rare tumors such as choroid plexus carcinoma due to her inspiring interactions with courageous children like Matthew Larson.